Collegium Pharmaceutical Announces $50M Accelerated Share Repurchase Agreement With Jefferies, With Initial Delivery Of 1,556,420 Shares; $100M To Remain Under Program
Share
Why It Matters
Collegium Pharmaceutical is buying back its own shares (ownership pieces) from investors using $50 million right now, which can sometimes mean leaders think their company is a good value. When a company buys back shares, each remaining share can become a bigger piece of the company's profits.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.